3 Matching Annotations
  1. Last 7 days
    1. Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas

      [Paper-level Aggregated] PMCID: PMC10161095

      Evidence Type(s): Oncogenic, Functional

      Justification: Oncogenic: The text describes how lysine-to-methionine mutations in histone H3 at lysine 27 (H3K27M) are associated with lethal childhood brain cancers, indicating that this variant contributes to tumorigenesis. Functional: The evidence shows that H3K27M mutations alter chromatin remodeling and affect protein levels of the SWI/SNF complex, demonstrating a functional impact on cellular processes related to cancer.

      Gene→Variant (gene-first): H3-3B(3021):lysine 27 PBRM1(55193):lysine-to-methionine

      Genes: H3-3B(3021) PBRM1(55193)

      Variants: lysine 27 lysine-to-methionine

    2. Diffuse midline gliomas (DMGs) including diffuse intrinsic pontine gliomas (DIPGs) bearing lysine-to-methionine mutations in histone H3 at lysine 27 (H3K27M) are lethal childhood brain cancers. These tumors harbor a glob

      [Paragraph-level] PMCID: PMC10161095 Section: ABSTRACT PassageIndex: 3

      Evidence Type(s): Oncogenic, Functional

      Justification: Oncogenic: The passage discusses how the lysine-to-methionine mutation at lysine 27 (H3K27M) contributes to tumor development and progression in diffuse midline gliomas, indicating its role as a somatic variant in cancer. Functional: The variant alters molecular function by affecting the levels of proteins in the SWI/SNF complex and influencing chromatin modifications, demonstrating its impact on biochemical processes within the tumor cells.

      Gene→Variant (gene-first): 3021:lysine 27 55193:lysine-to-methionine

      Genes: 3021 55193

      Variants: lysine 27 lysine-to-methionine

    3. Diffuse midline gliomas (DMGs) including diffuse intrinsic pontine gliomas (DIPGs) bearing lysine-to-methionine mutations in histone H3 at lysine 27 (H3K27M) are lethal childhood brain cancers. These tumors harbor a glob

      [Paragraph-level] PMCID: PMC10161095 Section: ABSTRACT PassageIndex: 3

      Evidence Type(s): Oncogenic, Functional

      Justification: Oncogenic: The passage discusses how the lysine-to-methionine mutation at lysine 27 (H3K27M) contributes to tumor development and progression in diffuse midline gliomas, indicating its role as a somatic variant in cancer. Functional: The variant alters molecular function by affecting the levels of proteins in the SWI/SNF complex and influencing chromatin modifications, demonstrating its impact on biochemical processes within the tumor cells.

      Gene→Variant (gene-first): 3021:lysine 27 55193:lysine-to-methionine

      Genes: 3021 55193

      Variants: lysine 27 lysine-to-methionine